Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
naldemedine
|
| gptkbp:approvalYear |
2017
|
| gptkbp:ATCCode |
gptkb:A06AH05
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Symproic
|
| gptkbp:indication |
opioid-induced constipation
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Shionogi_Inc.
|
| gptkbp:mechanismOfAction |
peripherally-acting mu-opioid receptor antagonist
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:bfsParent |
gptkb:DB11363
|
| gptkbp:bfsLayer |
7
|